Your browser doesn't support javascript.
loading
A plasma protein derived TGFß signature is a prognostic indicator in triple negative breast cancer.
Katayama, Hiroyuki; Tsou, Peiling; Kobayashi, Makoto; Capello, Michela; Wang, Hong; Esteva, Francisco; Disis, Mary L; Hanash, Samir.
Afiliação
  • Katayama H; 1MD Anderson Cancer Center, 6767 Bertner Avenue, Houston, TX 77030 USA.
  • Tsou P; 1MD Anderson Cancer Center, 6767 Bertner Avenue, Houston, TX 77030 USA.
  • Kobayashi M; 1MD Anderson Cancer Center, 6767 Bertner Avenue, Houston, TX 77030 USA.
  • Capello M; 1MD Anderson Cancer Center, 6767 Bertner Avenue, Houston, TX 77030 USA.
  • Wang H; 1MD Anderson Cancer Center, 6767 Bertner Avenue, Houston, TX 77030 USA.
  • Esteva F; 2Division of Hematology/Oncology, Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY 10016 USA.
  • Disis ML; 3Tumor Vaccine Group, University of Washington, 850 Republican Street, Box 358050, Seattle, WA 98109 USA.
  • Hanash S; 1MD Anderson Cancer Center, 6767 Bertner Avenue, Houston, TX 77030 USA.
NPJ Precis Oncol ; 3: 10, 2019.
Article em En | MEDLINE | ID: mdl-30963111
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article